
Today’s lung cancer treatments have become increasingly advanced, offering patients new hope.
1. Targeted Therapy
- EGFR Inhibitors: Drugs like Erlotinib and Gefitinib target specific mutations in the EGFR gene.
- ALK Inhibitors: Alectinib and Crizotinib block cancer cell growth associated with ALK gene rearrangements.
2. Immunotherapy
- Pembrolizumab: A PD-1 inhibitor that enhances the immune system’s ability to fight lung cancer.
- Nivolumab: Another immune checkpoint inhibitor that helps the immune system attack cancer cells.
3. Chemotherapy
- Standard treatment, often combined with targeted therapies or immunotherapies.
4. Radiation Therapy
- Used for localized lung cancer or to shrink tumors before surgery.
5. Surgical Options
- Lobectomy: Removal of a lobe of the lung.
- Pneumonectomy: Entire lung removal.
6. Clinical Trials
- Investigational therapies and combinations of existing treatments are being tested.
Statistics Overview
Treatment Type | Success Rate (%) |
---|---|
Targeted Therapy | 60% |
Immunotherapy | 30-40% |
Chemotherapy | 20-30% |
Surgery | 50-70% |
Mind Map of Lung Cancer Treatments
- Lung Cancer Treatments
- Targeted Therapy
- EGFR Inhibitors
- ALK Inhibitors
- Immunotherapy
- Pembrolizumab
- Nivolumab
- Chemotherapy
- Radiation Therapy
- Surgical Options
- Lobectomy
- Pneumonectomy
- Clinical Trials
- Targeted Therapy


